Pure Global

REDUCE Trial: Reducing the impact of diabetic foot ulcers (DFUs) - Trial ISRCTN15570706

Access comprehensive clinical trial information for ISRCTN15570706 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospitals of Derby and Burton NHS Foundation Trust and is currently status unknown. The study focuses on Diabetes mellitus. Target enrollment is 559 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ISRCTN Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ISRCTN15570706
behavioral
Trial Details
ISRCTN Registry โ€ข ISRCTN15570706
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
REDUCE Trial: Reducing the impact of diabetic foot ulcers (DFUs)
Reducing the impact of diabetic foot ulcers (REDUCE): A effectiveness and cost-effectiveness randomised controlled trial

Study Focus

Diabetes mellitus

Interventional

behavioral

Sponsor & Location

University Hospitals of Derby and Burton NHS Foundation Trust

NIHR Central Commissioning Facility (CCF)

United Kingdom

Timeline & Enrollment

N/A

May 01, 2018

Oct 31, 2025

559 participants

Summary

Participants who receive the REDUCE Intervention will have a greater number of ulcer free days compared to those who did not receive the REDUCE Intervention

ICD-10 Classifications

Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Unspecified diabetes mellitus with unspecified complications

Data Source

ISRCTN Registry

ISRCTN15570706

Non-Device Trial